文献速递临床试验与 GCP

胰腺癌手术患者多模式预康复(PIPS):随机对照试验研究方案

Multimodal Prehabilitation In Pancreatic cancer Patients undergoing surgery (PIPS): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2026-01-31

该方案描述一项单中心随机对照试验,在238例接受胰腺手术(直接手术或化疗后)的成人中,比较4-6周多模式预康复(身体、营养、心理干预)与常规围手术期护理。主要结局为术后并发症严重程度(综合并发症指数CCI®),随访至术后365天。

要点

  • 胰腺癌手术并发症率高达70%,术前功能储备低和营养不良与术后结局较差相关。
  • 该单中心随机对照试验计划纳入238例,比较4-6周多模式预康复与常规护理。
  • 主要结局为术后并发症严重程度(CCI®),随访至术后365天。

核心结论

  • 多模式预康复可能增强功能储备、改善营养状态、增加骨骼肌质量,从而促进从分解代谢向合成代谢转变。
  • 通过调节全身炎症、支持心血管和免疫功能,该策略可能减少术后并发症、缩短住院时间、加快健康相关生活质量恢复。
  • 若该试验取得阳性结果,将具有重要临床意义并可能改变实践,可能为胰腺癌手术患者实施多模式预康复的未来指南提供信息。

研究设计与样本

  • 单中心随机对照试验,评估4-6周多模式预康复方案(身体、营养和心理干预)与常规围手术期护理的比较。
  • 研究对象为计划接受胰腺手术的成人,无论直接手术还是胰腺或壶腹周围癌化疗后手术。
  • 样本量估计为238例患者,以提供足够把握度检测组间CCI®的临床意义差异。

主要发现

  • 胰腺癌手术具有挑战性,并发症率高达70%,导致术后恢复不佳和健康相关生活质量(HRQoL)差。
  • 既往研究显示术前功能储备低和营养不良与术后结局较差相关。
  • 考虑到老年和衰弱患者频率高、常因长程新辅助化疗而功能下降,术前阶段包括化疗后时间窗是调节可改变风险因素(如功能储备、营养状态)的独特机会。

关键数值与推荐

  • 主要结局为术后并发症严重程度,使用综合并发症指数(CCI®)测量。
  • 次要结局包括功能储备水平、功能恢复时间、住院时间、身体成分参数以及通用和疾病特异性健康相关生活质量(HRQoL)。
  • 随访评估将在术后30、60、90、180和365天进行。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreatic cancer surgery is challenging and associated with up to a 70% complication rate, which translates to poor postoperative recovery and patient health-related quality of life (HRQoL). Previous studies showed that preoperative low functional capacity and malnutrition have been associated with inferior postoperative outcomes. Considering the high frequency of older and frail patients, often deconditioned by long-course neoadjuvant chemotherapy, the preoperative period, including the time window after chemotherapy, is a unique opportunity to condition modifiable risk factors (e.g., functional capacity, nutritional status). This manuscript outlines the protocol for a randomized controlled trial investigating the impact of a multimodal prehabilitation program on postoperative complications and recovery following pancreatectomy. METHODS: This is a single-center, randomized controlled trial evaluating a 4-6-week multimodal prehabilitation program (physical, nutritional, and psychological interventions) compared with usual perioperative care in adults scheduled for pancreatic surgery, whether upfront or following chemotherapy for pancreatic or periampullary cancer. The primary outcome will be the severity of postoperative complications, measured using the Comprehensive Complication Index (CCI®). Secondary outcomes include the level of functional capacity, time to functional recovery, length of stay, body composition parameters, and generic and disease-specific health-related quality of life (HRQoL). Follow-up assessment will be conducted at 30, 60, 90, 180, and 365 days post-surgery. A sample size of 238 patients is estimated to provide adequate power to detect a clinically meaningful difference in CCI® between groups. DISCUSSION: A multimodal prehabilitation program may enhance functional capacity, improve nutritional status, and increase skeletal muscle mass, thereby promoting a shift from a catabolic to an anabolic state. By modulating systemic inflammation and supporting cardiovascular and immune function, this strategy could lead to fewer postoperative complications, a shorter length of stay, and a faster recovery of health-related quality of life. Positive findings from this trial would carry strong clinical significance and could be practice-changing, potentially informing future guidelines for the implementation of multimodal prehabilitation in patients undergoing pancreatic cancer surgery. TRIAL REGISTRATION: Trial Registry NCT06069297. Registered on August 25, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Pecorelli N, Fermi F, Abati M, et al. Multimodal Prehabilitation In Pancreatic cancer Patients undergoing surgery (PIPS): study protocol for a randomized controlled trial. Trials. 2026. PMID: 41618415. doi:10.1186/s13063-026-09467-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。